Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03376438 · ClinicalTrials.gov registry record
Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia
A clinical trial, sponsored by Edgar Jaeggi.
- Completed
- Registry status
- 330
- Enrollment target
NCT03376438: Completed study, sponsored by Edgar Jaeggi.
NCT03376438 is a clinical trial that has completed, run by Edgar Jaeggi. The registered enrollment target is 330 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03376438 has completed, sponsored by Edgar Jaeggi.
- COMPLETED
- Registry status
- 330 participants
- Enrollment target
Study Summary
The FAST Trial Registry is a prospective observational cohort study of fetuses with a new diagnosis of atrial flutter (AF) or supraventricular tachycardia (SVT) that is severe enough to consider prenatal treatment (see eligibility criteria below). Aims of the Registry include to establish a large clinical database to determine and compare the efficacy and safety of different prenatal treatment strategies including observation without immediate treatment, transplacental antiarrhythmic fetal treatment and direct fetal treatment from the time of tachycardia diagnosis to death, neonatal hospital discharge or to a maximum of 30 days after birth.
Interventions
- OTHER Prospective observational cohorts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 330 participants |
| Start Date | 2017-06-08 |
| Est. Completion | 2025-03-31 |
What the finished NCT03376438 record still lists
NCT03376438 is an observational study that tracks outcomes without assigning an intervention. The registered 330 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Prospective observational cohorts is the first listed.
NCT03376438 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03376438 about?
NCT03376438 is a clinical study titled "Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia". The FAST Trial Registry is a prospective observational cohort study of fetuses with a new diagnosis of atrial flutter (AF) or supraventricular tachycardia (SVT) that is severe enough to consider prenatal treatment (see eligibility criteria below). Aims of the Registry include to establish a large cl...
What is the current status of trial NCT03376438?
This trial is currently completed. The enrollment target is 330 participants. The study started on 2017-06-08. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT03376438?
The interventions under investigation include: Prospective observational cohorts (OTHER).
Who is sponsoring clinical trial NCT03376438?
This trial is sponsored by Edgar Jaeggi, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00359684 · 330 participants
Use of Cysteamine in the Treatment of Cystinosis
- NCT03817502 · 330 participants · Phase 3
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- NCT03922724 · 330 participants · Phase 2
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
- NCT03932773 · 330 participants · NA
Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI